Probucol decreases asymmetrical dimethylarginine level by alternation of protein arginine methyltransferase I and dimethylarginine dimethylaminohydrolase activity

Cardiovascular Drugs and Therapy

Volumn 20, Issue 4, 2006, Pages 281-294

  Jiang, Jun Lin ^a   Zhang, Xiao Hong ^a   Li, Nian Sheng ^a   Rang, Wei Qing ^a   Feng Ye, ^a   Hu, Chang Ping ^a   Li, Yuan Jian ^a   Deng, Han Wu ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Asymmetric dimethylarginine; Dimethylarginine dimethylaminohydrolase; Endothelium; Lysophosphatidylcholine; Oxidized low density lipoprotein; Probucol; Protein arginine methyltransferase 1

Indexed keywords

3,4 METHYLENEDIOXYAMPHETAMINE; ANTIOXIDANT; DIMETHYLARGININASE; LACTATE DEHYDROGENASE; LYSOPHOSPHATIDYLCHOLINE; METHYLTRANSFERASE; N(G),N(G) DIMETHYLARGININE; NITRATE; NITRIC OXIDE SYNTHASE INHIBITOR; NITRITE; OXIDIZED LOW DENSITY LIPOPROTEIN; PROBUCOL; PROTEIN ARGININE METHYLTRANSFERASE I; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; ARTICLE; CELL CULTURE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; INCUBATION TIME; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; WESTERN BLOTTING;

AMIDOHYDROLASES; ANTIOXIDANTS; ARGININE; CELL LINE; ENDOTHELIAL CELLS; HUMANS; L-LACTATE DEHYDROGENASE; LIPOPROTEINS, LDL; MALONDIALDEHYDE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; PROBUCOL; PROTEIN-ARGININE N-METHYLTRANSFERASE;

EID: 33750739568     PISSN: 09203206     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10557-006-9065-1     Document Type: Article

References (33)

1. Boger RH, Bode-Boger SM, Szuba A, et al. Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia. Circulation 1998;98:1842-7.
2. Yu XJ, Li YJ, Xiong Y. Increase of an endogenous inhibitor of nitric oxide synthesis in serum of high cholesterol fed rabbits. Life Sci 1994;54:753-8.
3. Bode-Böger SM, Böger RH, Kienke S, et al. Elevated L-arginine/dimethylarginine ratio contributes to enhanced systemic NO production by dietary L-arginine in hypercholesterolemic rabbits. Biochem Biophys Res Commun 1996;219:598-603.
4. Ito A, Tsao PS, Adimoolam S, et al. Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase. Circulation 1999;99:3092-5.
5. Scott HS, Antonarakis SE, Lalioti MD, et al. Identification and characterization of two putative human arginine methyltransferases (HRMT1L1 and HRMT1L2). Genomics 1998;48:330-40.
6. Boisvert FM, Cote J, Boulanger MC, et al. A proteomic analysis of arginine-methylated protein complexes. Mol Cell Proteomics 2003;2:1319-30.
7. Leiper JM, Maria JS, Chubb A, et al. Identification of two human dimethylarginine dimethylaminohydrolases with distinct tissue distributions and homology with microbial arginine deaminases. Biochem J 1999;99:3092-95.
8. Boger RH, Sydow K, Borlak J, et al. LDL cholesterol upregulates synthesis of asymmetrical dimethylarginine in human endothelial cells: involvement of S-adenosylmethionine-dependent methyltransferases. Circ Res 2000;87:99-105.
9. Jiang JL, Li NS, Li YJ, et al. Probucol preserves endothelial function by reduction of the endogenous nitric oxide synthase inhibitor level. Br J Pharmacol 2002;135:1175-82.
10. Selley ML. Homocysteine increases the production of asymmetric dimethylarginine in cultured neurons. J Neurosci Res 2004;77:90-3.
11. Havel RJ, Eder HA, Bragdon JH. The distribution and chemical composition of ultra-centrifugally separated lipoproteins in human serum. J Clin Invest 1995;34:1345-53.
12. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979;95:351-8.
13. Bessman JD, Gardner FH. Platelet size in thrombocytopenia due to sepsis. Surg Gynecol Obstet 1983;156:177-80.
14. Feng Q, Lu X, Jones DL, et al. Increased inducible nitric oxide synthase expression contributes to myocardial dysfunction and higher mortality after myocardial infarction in mice. Circulation 2001;104:700-4.
15. Chen BM, Xia LW, Zhao RQ. Determination of NG, NG-dimethylarginine in human plasma by high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl 1997;692:467-71.
16. Lin KY, Ito A, Asagami T, et al. Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase. Circulation 2002;106:987-92.
17. Vallance P, Leone A, Calver A, et al. Accumulation of an endogenous inhibitor of NO synthesis in chronic renal failure. Lancet 1992;339:572-5.
18. Kurose I, Wolf R, Grisham MB, et al. Effects of an endogenous inhibitor of nitric oxide synthesis on postcapillary venules. Am J Physiol 1995;268:H2224-31.
19. Yu XJ, Li YJ, Xiong Y. Increase of an endogenous inhibitor of nitric oxide synthesis in serum of high cholesterol fed rabbits. Life Sci 1994;54:753-8.
20. Usui M, Matsuoka H, Miyazaki H, et al. Increased endogenous nitric oxide synthase inhibitor in patients with congestive heart failure. Life Sci 1998;62:2425-30.
21. Boger RH, Bode-Boger SM, Tsao PS, et al. An endogenous inhibitor of nitric oxide synthase regulates endothelial adhesiveness for monocytes. J Am Coll Cardiol 2000;3:2287-95.
22. Chan JR, Boger RH, Bode-Boger SM, et al. Asymmetric dimethylarginine increases mononuclear cell adhesiveness in hypercholesterolemic humans. Arterioscler Thromb Vasc Biol 2000;20:1040-6.
23. Osanai T, Saitoh M, Sasaki S, et al. Effect of shear stress on asymmetric dimethylarginine release from vascular endothelial cells. Hypertension 2003;42:985-90.
24. Johnson BA, Najbauer J, Aswad DW. Accumulation of substrates for protein L-isoaspartyl methyltransferase in adenosine dialdehyde-treated PC12 cells. J Biol Chem 1993;268:6174-81.
25. Hanzelka BL, Greenberg EP. Quorum sensing in Vibrio fischeri: evidence that S-adenosylmethionine is the amino acid substrate for autoinducer synthesis. J Bacteriol 1996;178:5291-4.
26. Najbauer J, Johnson BA, Aswad DW. Analysis of stable protein methylation in cultured cells. Arch Biochem Biophys 1992;293:85-92.
27. Stuhlinger MC, Tsao PS, Her JH, et al. Homocysteine impairs the nitric oxide synthase pathway: role of asymmetrical dimethlarginine. Circulation 2000;104:2569-75.
28. Simon BC, Handenschild CC, Cohen RA. Preservation of endothelium- dependent relaxation in atherosclerotic rabbit aorta by probucol. J Cardiovasc Pharmacol 1993;21:893-901.
29. Liu GX, Ou DM, Li LX, et al. Probucol inhibits oxidized-low density lipoprotein-induced adhesion of monocytes to endothelial cells in vitro. Acta Pharmacol Sin 2002;23:516-22.
30. Kielstein JT, Impraim B, Simmel S, et al. Cardiovascular effects of systemic nitric oxide synthase inhibition with asymmetrical dimethylarginine in humans. Circulation 2004;109:172-7.
31. Pluta RM, Jung CS, Harvey-White J, et al. In vitro and in vivo effects of probucol on hydrolysis of asymmetric dimethyl L-arginine and vasospasm in primates. J Neurosurg 2005;103:731-8.
32. Tagawa T, Urabe Y, Kimura Y, et al. Long-term treatment with probucol improves endothelial function in patients with coronary artery disease. Hypertens Res 2004;27:311-8.
33. Fleming I, Mohamed A, Galle J, et al. Oxidized low-density lipoprotein increases superoxide production by endothelial nitric oxide synthase by inhibiting PKCalpha. Cardiovasc Res 2005;65:897-906.